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Allosteric Control of O2 Reactivity
in Rieske Oxygenases o
p
oOxygen is Nature’s perfect reagent. On one hand, it is t
potentially a very strong oxidant. On the other hand, n
this potential is caged because the two highest en- c
ergy valence electrons of the O2 molecule are un- m
paired. As a result, O2 is relatively unreactive with v
most other molecules, as almost all of these have c
paired electrons. Consequently, by modulating the b
properties of the O2 valence electrons, Nature can t
generate a reactive species under controlled condi- i
tions, catalyzing difficult reactions while still rigor- f
ously enforcing specificity. Special sets of enzymes o
termed oxygenases and oxidases have evolved to v
perform this task. c
e
The report by Dobbek and colleagues in this issue of m
Structure, describing the structural basis for the regula- a
tion of the O2 activation in the 2-oxoquinoline 8-mono- a
oxygenase oxygenase (OMO) component (Martins et c
al., 2005), adds a novel strategy to a remarkably varied o
set of approaches employed by Nature to regulate both o
when and where O2 activation occurs. Like so many p
other aspects of modern biological science, the pro-
posed mechanism has it roots in the mechanism of he- b
moglobin, ironically a protein specifically designed to m
obind and transport O without activating it. In this pro-2ein paradigm, allosteric interactions transmitted across
subunit boundary generate the cooperative binding
f O2 and allow it to be regulated through binding of
roton and organic-phosphate “effectors.” In the case
f OMO, a subunit boundary is again postulated to
ransmit allosteric effects. However, the effects origi-
ate from a change in the redox state of a Rieske Fe-S
luster and are transmitted across the interface to a
ononuclear iron site where O2 both binds and is acti-
ated. Dobbek and colleagues hypothesize that the
hange in Rieske iron-sulfur cluster redox state induces
inding of proton to a histidine ligand and that this, in
urn, initiates a cascade of shifts in hydrogen bonding
nteractions in a network that extends through the inter-
ace. Ultimately, these shifts unmask a coordination site
n the mononuclear iron, which then binds and acti-
ates O2. In this way, oxygen activation is allosterically
ontrolled, occurring only when the two electrons nec-
ssary to satisfy the stoichiometry of the enzyme’s
onooxygenase reaction [one from the Rieske cluster
nd the other from the mononuclear Fe(II)] are avail-
ble. Among its many features, this proposal would ac-
ount for Nature’s choice of a Rieske cluster instead of
ne of the more common type of FeS clusters for these
xygenases. Only the Rieske cluster has the readily
rotonated histidine ligands.
The relevance of the Dobbek mechanism to the
road family of Rieske oxygenases is supported by nu-
erous recent studies. The first X-ray crystal structures
f a Rieske-type oxygenase completed by Eklund and
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685colleagues in 1998 were of naphthalene 1,2-dioxygen-
ase (NDO) (Kauppi et al., 1998), an enzyme that inserts
both atoms of oxygen from O2 into the substrate rather
than one as for OMO. Nevertheless, there is nearly per-
fect structural homology in the vicinity of the metal cen-
ters and the subunit interface, showing that there is
likely to be a common mechanism for regulation of the
oxygen activation. The hydrogen bonding network be-
tween the metal centers was identified in the original
NDO study, but technical difficulties prevented determi-
nation of the structure in two redox states, the pivotal
advance reported in the current study. The essential na-
ture of the hydrogen bonding network in NDO was
established by site-directed mutagenesis in studies
published from the Gibson laboratory (Parales et al.,
1999). Finally, redox-related structural changes in the
vicinity of the Rieske center (Cosper et al., 2002) and
coordination number flexibility of the mononuclear site
(Gassner et al., 1993) have emerged from numerous
spectroscopic studies.
Recently, we have used single turnover reaction ki-
netics of reduced NDO and benzoate 1,2-dioxygenase
(BZDO) to show that the two electrons present in the
metal clusters are both utilized during product forma-
tion, implying that the electron transfer event between
the centers is critical for catalysis (Wolfe et al., 2001,
2002). Moreover, the use of NO as an O2 surrogate al-
lowed us to demonstrate that small-molecule access to
the mononuclear iron site is regulated by both sub-
strate binding and the redox state of the Rieske cluster.
Indeed the presence of allosteric coupling between the
Rieske and mononuclear-iron sites was first inferred
from an ENDOR spectroscopic study of the NDO-NO
complex with specifically deuterated substrates bound
in the active site; it showed an 0.5 Å shift in the position
of the substrate upon reduction of the 13 Å distant
Rieske cluster (Yang et al., 2003a, 2003b). Thus, studies
of the enzyme in solution are in perfect agreement with
the structural insights that have now emerged from the
X-ray crystal structure of OMO.
Oxygenases and oxidases use multiple strategies to
regulate O2 activation, and the current study shows that
elements of known strategies are recombined in a novel
form in OMO. It is likely that additional elements of reg-
ulation and mechanistic features of Rieske oxygenases
will emerge from future X-ray and ENDOR studies. For
example, it is currently unknown how the mononuclear
iron site of Rieske dioxygenases can promote both
monooxygenase and dioxygenase chemistry, and the
current availability of structures for both types of
Rieske oxygenases will permit detailed comparisons.
Also, while current information shows how OMO can
link a redox reaction to O2 activation, it does not reveal
how the activation process is coupled to substrate
binding. As alluded to above, spectroscopic studiesclearly show that the probe molecule NO does not bind
to the iron in fully reduced NDO prior to substrate addi-
tion (Wolfe et al., 2001). If this is also true of O2, then
Nature has devised a mechanism to insure that two
electrons and substrate are present before O2 activa-
tion. In the case of NDO, the crystal structures of both
substrate-free and bound oxygen adducts have been
reported (Karlsson et al., 2003). While this may mean
that the enzyme binds O2 differently than NO, this
seems unlikely because activation of O2 without sub-
strate would result in the uncontrolled release of acti-
vated oxygen species, which is neither observed in so-
lution nor tolerated in biology.
Reactive oxygen species can be toxic in humans,
and oxygen under high pressure is a poison, yet hu-
mans and all other aerobic organisms on earth have
adapted to, and indeed require, abundant oxygen.
Thus, adaptive pressure to regulate oxygen reactivity is
relentless. OMO provides a fresh example of the diver-
sity with which Nature has responded to this challenge.
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